Improving Quality With Outpatient Decision Support

This study has been completed.
Sponsor:
Information provided by:
Agency for Healthcare Research and Quality (AHRQ)
ClinicalTrials.gov Identifier:
NCT00225628
First received: September 22, 2005
Last updated: September 23, 2005
Last verified: September 2005
  Purpose

Assesses physician compliance with paper-based and electronic guidelines, reminders, and alerts for outpatient settings. Target areas for the reminders and alerts are disease management, medication management, and interpretation of abnormal test results.


Condition Intervention
Diabetes Mellitus
Coronary Artery Disease
Osteoporosis
Hypertension
Hyperlipidemia
Behavioral: Computerized Reminders Medications Monitoring
Behavioral: Computerized Test Results Management Application
Behavioral: Computerized Reminders Hypertension Management
Behavioral: Computerized Reminders Osteoporosis Screening and Mgt

Study Type: Interventional
Study Design: Allocation: Randomized
Endpoint Classification: Safety/Efficacy Study
Intervention Model: Parallel Assignment
Masking: Open Label
Primary Purpose: Prevention
Official Title: Improving Quality With Outpatient Decision Support

Resource links provided by NLM:


Further study details as provided by Agency for Healthcare Research and Quality (AHRQ):

Primary Outcome Measures:
  • 1) Compliance to guidelines regarding the outpatient laboratory monitoring of prescription medication regiments
  • 2) Compliance to guidelines regarding the follow-up of abnormal test results, including critically abnormal test results, abnormal cholesterol, abnormal HbA1c, abnormal pap smears and abnormal mammogram
  • 3) Compliance to guidelines regarding the management of hypertension in the general ambulatory population and amongst ethnic minority groups
  • 4) Compliance to guidelines regarding the screening and management of osteoporosis

Secondary Outcome Measures:
  • 1) Patient satisfaction regarding communication with physicians
  • 2) Physician satisfaction regarding follow-up of abnormal test results

Estimated Enrollment: 3000
Study Start Date: September 2000
Estimated Study Completion Date: December 2006
  Show Detailed Description

  Eligibility

Ages Eligible for Study:   18 Years and older
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • All physicians in on-site and satellite adult outpatient clinics with the Brigham and Women's Hospital and Massachusetts General Hospital.
  • All practices must have adopted our home-grown electronic health record system, the Longitudinal Medical Record, for at least 24 months prior to the start of each intervention trial.

Exclusion Criteria:

  • None
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT00225628

Locations
United States, Massachusetts
Brigham and Women's Hospital
Boston, Massachusetts, United States, 02472
Sponsors and Collaborators
Investigators
Principal Investigator: David W Bates, MD MSc Brigham and Women's Hospital
  More Information

Publications:

Additional publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):
ClinicalTrials.gov Identifier: NCT00225628     History of Changes
Other Study ID Numbers: 5 U18 HS011046
Study First Received: September 22, 2005
Last Updated: September 23, 2005
Health Authority: United States: Federal Government

Keywords provided by Agency for Healthcare Research and Quality (AHRQ):
Computerized clinical decision support
Patient Safety
Quality of Care
Electronic Medical Records
Chronic Disease Management
Drug Monitoring
Guideline Adherence
Reminder Systems

Additional relevant MeSH terms:
Coronary Artery Disease
Myocardial Ischemia
Coronary Disease
Diabetes Mellitus
Hyperlipidemias
Hypertension
Osteoporosis
Heart Diseases
Cardiovascular Diseases
Arteriosclerosis
Arterial Occlusive Diseases
Vascular Diseases
Glucose Metabolism Disorders
Metabolic Diseases
Endocrine System Diseases
Dyslipidemias
Lipid Metabolism Disorders
Bone Diseases, Metabolic
Bone Diseases
Musculoskeletal Diseases

ClinicalTrials.gov processed this record on August 28, 2014